Variant report
Variant | nsv982847 |
---|---|
Chromosome Location | chr10:37549675-37560381 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs572526830 | chr10:37550247-37550248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs541549113 | chr10:37550258-37550259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs181194785 | chr10:37550363-37550364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs35329195 | chr10:37550376-37550377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140061444 | chr10:37550393-37550394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183928289 | chr10:37550415-37550416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563792341 | chr10:37550428-37550429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540644972 | chr10:37550432-37550433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs74486817 | chr10:37550440-37550441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs368679419 | chr10:37550474-37550475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs149597946 | chr10:37550488-37550489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550810768 | chr10:37550507-37550508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs545428628 | chr10:37550544-37550545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188264822 | chr10:37550580-37550581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532941020 | chr10:37550581-37550582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528163744 | chr10:37550682-37550683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546324822 | chr10:37550784-37550785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs558949901 | chr10:37550797-37550798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs11011080 | chr10:37550853-37550854 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs557270621 | chr10:37550889-37550890 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs377442710 | chr10:37550938-37550939 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570627049 | chr10:37550967-37550968 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs539724756 | chr10:37550983-37550984 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs535482451 | chr10:37550998-37550999 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558952306 | chr10:37551097-37551098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566122034 | chr10:37551109-37551110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535120811 | chr10:37551280-37551281 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs555132322 | chr10:37551358-37551359 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs576956063 | chr10:37551366-37551367 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575072903 | chr10:37551387-37551388 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs543622383 | chr10:37551394-37551395 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs557531983 | chr10:37551458-37551459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs577424234 | chr10:37551490-37551491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144282010 | chr10:37551507-37551508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558919898 | chr10:37551592-37551593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs201189167 | chr10:37551599-37551600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs374096469 | chr10:37551625-37551626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs548706756 | chr10:37551764-37551765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs148730238 | chr10:37551793-37551794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374017547 | chr10:37551852-37551853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs142249214 | chr10:37551875-37551876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146520623 | chr10:37551886-37551887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs139955326 | chr10:37551887-37551888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181923040 | chr10:37551902-37551903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568797653 | chr10:37551951-37551952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs533070332 | chr10:37551957-37551958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs546964613 | chr10:37552001-37552002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs566060676 | chr10:37552005-37552006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs538174934 | chr10:37552016-37552017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs535055734 | chr10:37552020-37552021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Behavioral abnormalities | 21522184 | CNVD |
Dysmorphic features | 21522184 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Bethlem myopathy | 20302629 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:37550200-37550800 | Enhancers | A549 | lung |
2 | chr10:37550800-37551000 | Flanking Active TSS | A549 | lung |
3 | chr10:37550800-37551400 | Enhancers | Rectal Smooth Muscle | rectum |
4 | chr10:37551000-37551200 | Enhancers | A549 | lung |
5 | chr10:37551200-37551400 | Flanking Active TSS | A549 | lung |
6 | chr10:37551400-37552600 | Weak transcription | A549 | lung |
7 | chr10:37552600-37553800 | Enhancers | A549 | lung |
8 | chr10:37553200-37553600 | Active TSS | Fetal Heart | heart |
9 | chr10:37553600-37558200 | Weak transcription | Fetal Heart | heart |
10 | chr10:37553800-37558000 | Weak transcription | A549 | lung |
11 | chr10:37554400-37554800 | Enhancers | Adipose Nuclei | Adipose |
12 | chr10:37556800-37557000 | Enhancers | Adipose Nuclei | Adipose |
13 | chr10:37558000-37559400 | Enhancers | Colon Smooth Muscle | Colon |
14 | chr10:37558000-37559400 | Enhancers | A549 | lung |